Repository logo
 
Publication

Does Cystatin C have a role as metabolic surrogate in peritoneal dialysis beyond its association with residual renal function?

dc.contributor.authorLeal Moreira, Carla
dc.contributor.authorCunha, Liliana
dc.contributor.authorCorreia, Sofia
dc.contributor.authorSilva, Filipa
dc.contributor.authorCastro, Ana
dc.contributor.authorTavares, Joana Manuel
dc.contributor.authorCarvalho, Maria João
dc.contributor.authorOliveira, José Carlos
dc.contributor.authorSantos, Maria Olivia
dc.contributor.authorCabrita, Antonio
dc.contributor.authorRodrigues, Anabela
dc.date.accessioned2022-01-11T15:34:03Z
dc.date.available2022-01-11T15:34:03Z
dc.date.issued2020
dc.description.abstractIntroduction: It has been suggested that cystatin C levels are modified by obesity and inflammation. Furthermore, cystatin C has been associated with cardiovascular events and mortality outcomes. Aim: To study the association of cystatin C with the metabolic profile and cardiovascular disease of peritoneal dialysis patients. Methods: Data collected included clinical, laboratorial, and multifrequency bioimpedance assessment of 52 stable peritoneal dialysis patients. Minimal residual renal function was defined as > 2mL/min/1.73m2. Results: Serum cystatin C was not significantly associated with peritoneal or urinary cystatin C excretion. Negative correlation of cystatin C with normalized protein catabolic rate (rho -0.33, p = 0.02) and a trend towards positive correlation with relative body fat (rho 0.27, p = 0.05) were not independent from residual renal function. Cystatin C was not significantly associated with cardiovascular disease (p = 0.28), nor with glycated hemoglobin (p = 0.19) or c-reactive protein (p = 0.56). In the multivariate model, both age and diabetes were the strongest predictors of cardiovascular disease (odds ratio 1.09, p = 0.029 and odds ratio 29.95, p = 0.016, respectively), while relative body fat was negatively associated with cardiovascular disease (p = 0.038); neither cystatin C (p = 0.096) nor minimal residual renal function (p = 0.756) reached a significant association with cardiovascular disease. Conclusions: In this group of peritoneal dialysis patients, cystatin C did not correlate with the metabolic or inflammatory status, nor cardiovascular disease, after adjustment for residual renal function.pt_PT
dc.description.abstractIntrodução:: Tem sido sugerido que os níveis de cistatina C são modificados pela obesidade e inflamação. Além disso, a cistatina C tem sido associada a eventos cardiovasculares e desfechos de mortalidade. Objetivo:: Estudar a associação da cistatina C com o perfil metabólico e doença cardiovascular de pacientes em diálise peritoneal. Métodos:: Os dados coletados incluíram avaliação clínica, laboratorial e de bioimpedância múltipla de 52 pacientes estáveis em diálise peritoneal. A função renal residual mínima foi definida como > 2mL/min/1,73m2. Resultados:: A cistatina C sérica não esteve significativamente associada à excreção peritoneal ou urinária. A correlação negativa da cistatina C com a taxa catabólica protéica normalizada (rho -0,33, p = 0,02) e uma tendência de correlação positiva com a gordura corporal relativa (rho 0,27, p = 0,05) não foram independentes da função renal residual. A cistatina C não se associou significativamente à doença cardiovascular (p = 0,28), nem com hemoglobina glicada (p = 0,19) ou proteína C reativa (p = 0,56). No modelo multivariado, idade e diabetes foram os mais fortes preditores de doença cardiovascular (razões de probabilidade 1,09, p = 0,029 e 29,95, p = 0,016, respectivamente) enquanto a gordura corporal relativa se associou negativamente à doença cardiovascular (p = 0,038). A cistatina C não se associou significativamente com doença cardiovascular (p = 0,096), tampouco a função residual mínima (p = 0,756). Conclusão:: Neste grupo de pacientes em diálise peritoneal, a cistatina C não se correlacionou com o estado metabólico ou inflamatório, nem com doença cardiovascular, após ajuste para função renal residual.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationMoreira CL, Cunha L, Correia S, et al. Does Cystatin C have a role as metabolic surrogate in peritoneal dialysis beyond its association with residual renal function?. J Bras Nefrol. 2020;42(1):31-37. doi:10.1590/2175-8239-JBN-2019-0007pt_PT
dc.identifier.doi10.1590/2175-8239-jbn-2019-0007pt_PT
dc.identifier.issn0101-2800
dc.identifier.issn2175-8239
dc.identifier.urihttp://hdl.handle.net/10400.16/2656
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherSociedade Brasileira de Nefrologiapt_PT
dc.relation.publisherversionhttps://www.scielo.br/j/jbn/a/3FhD9xWBMPqv3hjNDXRhdpw/?lang=en#pt_PT
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt_PT
dc.subjectCystatin Cpt_PT
dc.subjectCardiovascular Diseasespt_PT
dc.subjectPeritoneal Dialysispt_PT
dc.titleDoes Cystatin C have a role as metabolic surrogate in peritoneal dialysis beyond its association with residual renal function?pt_PT
dc.title.alternativeTeria a Cistatina C um papel como substituto metabólico na diálise peritoneal além de sua associação com a função renal residual?pt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.conferencePlaceBrazilpt_PT
oaire.citation.endPage37pt_PT
oaire.citation.issue1pt_PT
oaire.citation.startPage31pt_PT
oaire.citation.titleBrazilian Journal of Nephrologypt_PT
oaire.citation.volume42pt_PT
person.familyNameLeal Moreira
person.familyNameCunha
person.familyNameCorreia
person.familyNameSilva
person.familyNameCastro
person.familyNameTavares
person.familyNameCarvalho
person.familyNameOliveira
person.familyNameSantos
person.familyNameCabrita
person.familyNameSoares Rodrigues
person.givenNameCarla
person.givenNameLiliana
person.givenNameSofia
person.givenNameFilipa
person.givenNameAna
person.givenNameJoana Manuel
person.givenNameMaria João
person.givenNameJosé Carlos
person.givenNameMaria Olivia
person.givenNameAntonio
person.givenNameAnabela
person.identifier806053
person.identifier.ciencia-idC012-7D92-E4A3
person.identifier.ciencia-id801F-D4FE-8694
person.identifier.ciencia-id651F-A9D2-2136
person.identifier.orcid0000-0002-7913-4460
person.identifier.orcid0000-0002-5271-0640
person.identifier.orcid0000-0001-5025-1658
person.identifier.orcid0000-0002-7818-6453
person.identifier.orcid0000-0001-8328-2805
person.identifier.orcid0000-0002-3776-4923
person.identifier.orcid0000-0003-4374-2867
person.identifier.orcid0000-0003-2142-6839
person.identifier.orcid0000-0002-0193-3625
person.identifier.orcid0000-0003-3794-9239
person.identifier.orcid0000-0001-8818-2141
person.identifier.ridK-5226-2013
person.identifier.scopus-author-id57211840457
person.identifier.scopus-author-id7202269896
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublication601153a6-9e9a-43e1-a395-3e00cbe30a19
relation.isAuthorOfPublication9aaa56c1-d4a2-4c1c-9b6d-0e6fe092e21c
relation.isAuthorOfPublicationdbcc1fe0-e968-41f6-96ea-102866e84cb5
relation.isAuthorOfPublication37acea6a-952d-44eb-a090-1083ab9f750d
relation.isAuthorOfPublication84cd7cbf-1683-4893-a73a-da16a8a4cdd3
relation.isAuthorOfPublication0041f233-9581-41f2-a89c-cd7a962d9fa1
relation.isAuthorOfPublication7ef2e576-fcc9-4d57-aa6c-07d4f20935ff
relation.isAuthorOfPublicationbd6d8008-2622-4368-8ded-4ec1c1160c82
relation.isAuthorOfPublicationa2b979af-145b-47ae-9483-d9d9776cc20d
relation.isAuthorOfPublicatione6585113-b703-4899-ab35-2dfd11593588
relation.isAuthorOfPublication2276a1c5-40fe-41e9-a369-a40049bf81e3
relation.isAuthorOfPublication.latestForDiscovery84cd7cbf-1683-4893-a73a-da16a8a4cdd3

Files

Original bundle
Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
Moreira - 2020_ing.pdf
Size:
157.65 KB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
Moreira - 2020_Pt.pdf
Size:
184.42 KB
Format:
Adobe Portable Document Format